H
Hideki Watanabe
Researcher at Jichi Medical University
Publications - 43
Citations - 5926
Hideki Watanabe is an academic researcher from Jichi Medical University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 13, co-authored 36 publications receiving 5406 citations. Previous affiliations of Hideki Watanabe include Nagoya University & Eisai.
Papers
More filters
Journal ArticleDOI
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Manabu Soda,Young Lim Choi,Munehiro Enomoto,Shuji Takada,Yoshihiro Yamashita,Shunpei Ishikawa,Shin-ichiro Fujiwara,Hideki Watanabe,Kentaro Kurashina,Hisashi Hatanaka,Masashi Bando,Shoji Ohno,Yuichi Ishikawa,Hiroyuki Aburatani,Toshiro Niki,Yasunori Sohara,Yukihiko Sugiyama,Hiroyuki Mano +17 more
TL;DR: It is shown that a small inversion within chromosome 2p results in the formation of a fusion gene comprising portions of the echinoderm microtubule-associated protein-like 4 (EML4) gene and the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer (NSCLC) cells.
Journal ArticleDOI
Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non–Small Cell Lung Cancer
Young Lim Choi,Kengo Takeuchi,Manabu Soda,Kentaro Inamura,Yuki Togashi,Satoko Hatano,Munehiro Enomoto,Toru Hamada,Hidenori Haruta,Hideki Watanabe,Kentaro Kurashina,Hisashi Hatanaka,Toshihide Ueno,Shuji Takada,Yoshihiro Yamashita,Yukihiko Sugiyama,Yuichi Ishikawa,Hiroyuki Mano +17 more
TL;DR: Two slightly different fusion cDNAs in which exon 6 of EML4 was joined to exon 20 of ALK were each identified in two individuals of the cohort and exhibited marked transforming activity in vitro as well as oncogenic activity in vivo.
Journal ArticleDOI
Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models.
Yasuhiro Funahashi,Kiyoshi Okamoto,Yusuke Adachi,Taro Semba,Mai Uesugi,Yoichi Ozawa,Osamu Tohyama,Taisuke Uehara,Takayuki Kimura,Hideki Watanabe,Makoto Asano,Satoshi Kawano,Xavier Tizon,Paul J. McCracken,Junji Matsui,Ken Aoshima,Kenichi Nomoto,Yoshiya Oda +17 more
TL;DR: It is shown that eribulin induces remodeling of tumor vasculature through a novel antivascular activity in MX‐1 and MDA‐MB‐231 human breast cancer xenograft models, suggesting that Eribulin‐induced remodelling of abnormal tumor vasculation leads to a more functional microenvironment that may reduce the aggressiveness of tumors due to elimination of inner tumor hypoxia.
Journal ArticleDOI
Mouse microRNA profiles determined with a new and sensitive cloning method
Shuji Takada,Eugene Berezikov,Yoshihiro Yamashita,Mariana Lagos-Quintana,Wigard P. Kloosterman,Munehiro Enomoto,Hisashi Hatanaka,Fujiwara Si,Hideki Watanabe,Manabu Soda,Young Lim Choi,Ronald H.A. Plasterk,Edwin Cuppen,Hiroyuki Mano +13 more
TL;DR: The data indicate that the total number of miRNAs in vertebrates is larger than previously appreciated and that the expression of these molecules is tightly controlled in a tissue- and developmental stage-specific manner.
Journal ArticleDOI
Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR–MAPK cascades
Taisuke Hoshi,Saori Watanabe Miyano,Hideki Watanabe,Kanada Sonobe Regina,Yuki Seki,Etsuko Ohta,Kenichi Nomoto,Junji Matsui,Yasuhiro Funahashi +8 more
TL;DR: Results reveal that the F GF signaling pathway through MAPK cascades plays an important role in survival of HCC cell lines with an activated FGF signaling pathway under limited nutrients, and FGFR-MAPK cascade likely contribute to survival ofHCC cells with anactivated FGF signaled pathway under tumor microenvironments with limited nutrients.